eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors

  1. Hijazi, M.
  2. Casado, P.
  3. Akhtar, N.
  4. Alvarez-Teijeiro, S.
  5. Rajeeve, V.
  6. Cutillas, P.R.
Zeitschrift:
Molecular and Cellular Proteomics

ISSN: 1535-9484,  1535-9476

Datum der Publikation: 2022

Ausgabe: 21

Nummer: 7

Art: Artikel

DOI: 10.1016/J.MCPRO.2022.100240 GOOGLE SCHOLAR lock_openOpen Access editor